IIC
AMED

Integrated Investment Consultants’s Amedisys AMED Stock Holding History

Integrated Investment Consultants’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,562
Closed -$269K – 244
2022
Q1 		$269K Hold
1,562
– – 0.07% 240
2021
Q4 		$253K Buy
+1,562
New +$251K 0.07% 256
2021
Q3 		– Sell
-1,063
Closed -$260K – 287
2021
Q2 		$260K Buy
1,063
+199
+23% +$52.2K 0.08% 231
2021
Q1 		$229K Hold
864
– – 0.08% 227
2020
Q4 		$253K Hold
864
– – 0.1% 198
2020
Q3 		$204K Buy
+864
New +$196K 0.1% 188

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Integrated Investment Consultants's AMED Position: Q2 2022 in Review

Integrated Investment Consultants sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,562 shares — an estimated $269K sold.

Integrated Investment Consultants first reported a position in AMED in Q3 2020 and held it in 6 quarters. The position peaked at $269K in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Integrated Investment Consultants reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Integrated Investment Consultants sold 1,562 Amedisys shares in Q2 2022, an estimated $269K.
  • Integrated Investment Consultants first reported a position in Amedisys in Q3 2020 and held it in 6 quarters.
  • Integrated Investment Consultants's Amedisys position peaked at $269K in Q1 2022.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Integrated Investment Consultants's 13F filing for Q2 2022, filed 19 Jul 2022.